Additionally, it has been observed that the GPR40 agonist GW9508 can effectively mitigate cognitive impairments in mouse models of Alzheimer’s disease induced by A1-42 [16]. Here, FFAR1 is linked to early-onset autosomal dominant Alzheimer disease.